ULCERATIVE COLITIS (UC)
Clinical trials for ULCERATIVE COLITIS (UC) explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS (UC) trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS (UC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for maintaining ulcerative colitis remission
Disease control OngoingThis study tests whether risankizumab can help people with ulcerative colitis stay in remission for up to a year and beyond. Over 1,200 participants who already improved with risankizumab will receive either the drug or a placebo. The goal is to see if the drug can keep symptoms …
Matched conditions: ULCERATIVE COLITIS (UC)
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New pill shows promise for Long-Term control of ulcerative colitis
Disease control OngoingThis study tests the long-term safety and effectiveness of upadacitinib, a daily pill, for people with ulcerative colitis (UC) who did not get better with earlier treatment. About 950 adults and teens will take the drug for up to several years. The goal is to see if the drug can …
Matched conditions: ULCERATIVE COLITIS (UC)
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New study probes daily life with IBD
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how inflammatory bowel disease (IBD) impacts quality of life. Researchers will survey 385 adults with Crohn's disease or ulcerative colitis about their symptoms, emotions, and social support. No treatments or medications are tested; the goal is simpl…
Matched conditions: ULCERATIVE COLITIS (UC)
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated May 01, 2026 20:57 UTC